Search Results - "Vervoort, G."

Refine Results
  1. 1

    Dual-task-related neural connectivity changes in patients with Parkinson’ disease by Vervoort, G, Heremans, E, Bengevoord, A, Strouwen, C, Nackaerts, E, Vandenberghe, W, Nieuwboer, A

    Published in Neuroscience (11-03-2016)
    “…Highlights • Motor control areas involved in dual-tasking show altered functional connectivity in patients with Parkinson’s disease. • Hyper-connectivity…”
    Get full text
    Journal Article
  2. 2

    Start of insulin therapy in patients with type 2 diabetes mellitus promotes the influx of macrophages into subcutaneous adipose tissue by Jansen, H. J., Stienstra, R., van Diepen, J. A., Hijmans, A., van der Laak, J. A., Vervoort, G. M. M., Tack, C. J.

    Published in Diabetologia (01-12-2013)
    “…Aims/hypothesis Insulin therapy in patients with type 2 diabetes mellitus is accompanied by weight gain characterised by an increase in abdominal fat mass. The…”
    Get full text
    Journal Article
  3. 3

    Center of mass trajectories during turning in patients with Parkinson's disease with and without freezing of gait by Bengevoord, A, Vervoort, G, Spildooren, J, Heremans, E, Vandenberghe, W, Bloem, B.R, Nieuwboer, A

    Published in Gait & posture (01-01-2016)
    “…Highlights • Freezers showed a reduced step width compared to non-freezers during turning. • In turning sections preceding actual freezing episodes, step width…”
    Get full text
    Journal Article
  4. 4

    Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation by Vervoort, Gerald, Willems, Hans L., Wetzels, Jack F. M.

    Published in Nephrology, dialysis, transplantation (01-11-2002)
    “…Background. Based on the data derived from the Modification of Diet in Renal Disease (MDRD) study, a new equation was developed for the estimation of…”
    Get full text
    Journal Article
  5. 5

    A cost-controlling treatment strategy of adding liraglutide to insulin in type 2 diabetes by de Wit, H M, Vervoort, G M M, de Galan, B E, Tack, C J

    Published in Netherlands journal of medicine (01-09-2017)
    “…Addition of the GLP-1 receptor agonist liraglutide to insulin can reverse insulin-associated weight gain, improve HbA1c and decrease the need for insulin, but…”
    Get full text
    Journal Article
  6. 6

    Serum creatinine is a poor marker of GFR in nephrotic syndrome by Branten, Amanda J. W., Vervoort, Gerald, Wetzels, Jack F. M.

    Published in Nephrology, dialysis, transplantation (01-04-2005)
    “…Background. In daily clinical practice creatinine clearance is used as marker of glomerular filtration rate (GFR). As a result of the tubular secretion process…”
    Get full text
    Journal Article
  7. 7

    Validation of the kidney failure risk equation in European CKD patients by Peeters, Mieke J, van Zuilen, Arjan D, van den Brand, Jan A J G, Bots, Michiel L, Blankestijn, Peter J, Wetzels, Jack F M

    Published in Nephrology, dialysis, transplantation (01-07-2013)
    “…Patients with chronic kidney disease (CKD) are at risk for progression to kidney failure. Using data of Canadian CKD patients, Tangri et al. recently developed…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Glomerular hyperfiltration in type 1 diabetes mellitus results from primary changes in proximal tubular sodium handling without changes in volume expansion by Vervoort, G., Veldman, B., Berden, J. H. M., Smits, P., Wetzels, J. F. M.

    Published in European journal of clinical investigation (01-05-2005)
    “…Background  Glomerular hyperfiltration plays a role in the pathophysiology of diabetic nephropathy. An increase in the glomerular filtration rate (GFR) could…”
    Get full text
    Journal Article
  10. 10

    Contribution of change in glycosylated haemoglobin to insulin-associated weight gain: results of a longitudinal study in type 2 diabetic patients by Jansen, H. J., Hendriks, J. C., de Galan, B. E., Penders, G., Tack, C. J., Vervoort, G.

    Published in Endocrine (01-04-2011)
    “…To investigate the contribution of glycosylated haemoglobin change (HbA1c) on body weight in patients with type 2 diabetes after start of insulin therapy. We…”
    Get full text
    Journal Article
  11. 11

    Pronounced weight gain in insulin-treated patients with type 2 diabetes mellitus is associated with an unfavourable cardiometabolic risk profile by JANSEN, H. J, VERVOORT, G, VAN DER GRASF, M, TACK, C. J

    Published in Netherlands journal of medicine (01-11-2010)
    “…Pronounced weight gain after start of insulin therapy in patients with type 2 diabetes mellitus (T2DM) may offset beneficial effects conferred by the…”
    Get full text
    Journal Article
  12. 12

    Nurse practitioners improve quality of care in chronic kidney disease: two-year results of a randomised study by VAN ZUILEN, A. D, BLANKESTIJN, P. J, VLEMING, L, BOTS, M. L, WETZELS, J. F. M, VAN BUREN, M, TEN DAM, M. A. G. J, KAASJAGER, K. A. H, LIGTENBERG, G, SIJPKENS, Y. W. J, SLUITER, H. E, VAN DE VEN, P. J. G, VERVOORT, G

    Published in Netherlands journal of medicine (01-11-2011)
    “…Chronic kidney disease (CKD) is associated with increased cardiovascular risk. Here we evaluate whether strict implementation of guidelines aimed at multiple…”
    Get full text
    Journal Article
  13. 13

    Reduced plasma total homocysteine concentrations in Type 1 diabetes mellitus is determined by increased renal clearance by Veldman, B. A. J., Vervoort, G., Blom, H., Smits, P.

    Published in Diabetic medicine (01-03-2005)
    “…Introduction  Elevated plasma levels of total homocysteine are related to the development of vascular complications. Patients with diabetes mellitus are…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Quantitative assessment of DNA fragmentation and beta-amyloid deposition in insular cortex and midfrontal gyrus from patients with Alzheimer's disease by Colurso, Gloria J, Nilson, James E, Vervoort, Lucia G

    Published in Life sciences (1973) (22-08-2003)
    “…It has been suggested that the neurodegeneration that occurs with Alzheimer's disease (AD) may result from apoptosis, a process of programmed cell death…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Hospital specific factors affect quality of blood pressure treatment in chronic kidney disease by VAN ZUILEN, A. D, BLANKESTIJN, P. J, VLEMING, L, BOTS, M. L, WETZELS, J. F. M, VAN BUREN, M, TEN DAM, M. A. G. J, KAASJAGER, K. A. H, LIGTENBERG, G, SIJPKENS, Y. W. J, SLUITER, H. E, VAN DE VEN, P. J. G, VERVOORT, G

    Published in Netherlands journal of medicine (01-05-2011)
    “…Blood pressure (BP) is the most important modifiable risk factor for cardiovascular (CV) disease and progression of kidney dysfunction in patients with chronic…”
    Get full text
    Journal Article
  18. 18

    Low concentrations of intravenous polygelines promote low-molecular weight proteinuria by Veldman, B. A. J., Schepkens, H. L. E., Vervoort, G., Klasen, I., Wetzels, J. F. M.

    Published in European journal of clinical investigation (01-11-2003)
    “…Background  Previously we observed that atrial natriuretic peptide (ANP)‐induced albuminuria was accompanied by an increase in urinary excretion of the…”
    Get full text
    Journal Article
  19. 19

    Aging and hepatotoxicity of isoniazid and rifampin in pulmonary tuberculosis by van den Brande, P, van Steenbergen, W, Vervoort, G, Demedts, M

    “…We evaluated whether elderly patients with pulmonary tuberculosis and without apparent preexisting liver disease are at an increased risk to develop…”
    Get more information
    Journal Article
  20. 20